8/12/2013

Legislation in the Senate can help bolster the safety of compounded drugs by clarifying the obligations of the FDA and state regulatory agencies and by differentiating traditional compounding pharmacies from drug factories disguised as pharmacies, writes National Association of Boards of Pharmacy Executive Director Carmen Catizone.

Related Summaries